ROVIPHARM
Manufacturer • France · 7 devices on the TGA ARTG · 1 device class · Apr 29, 2004 – Jun 20, 2024
7
Total Devices
1
Device Classes
2004
Earliest
2024
Latest
Recent device registrations
Latest 10 TGA ARTG device registrations
Oral/enteral syringe, reusable
ARTG 453007
Class ImJun 20, 2024
Sponsor: Accelera Biopharma Pty Ltd
Oral/enteral syringe, reusable
Class ImJun 20, 2024
Sponsor: Accelera Biopharma Pty Ltd
Dispenser, medication, liquid
Class ImAug 26, 2021
Sponsor: ONELIFE LABS PTY LTD
Dispenser, medication, liquid
ARTG 373583
Class ImAug 26, 2021
Sponsor: ONELIFE LABS PTY LTD
Dispenser, medication, liquid
Class ImFeb 02, 2011
Sponsor: GlaxoSmithKline Australia Pty Ltd
Dispenser, medication, liquid
ARTG 101154
Class ImApr 29, 2004
Sponsor: Sanofi-Aventis Australia Pty Ltd
Dispenser, medication, liquid
Class ImApr 29, 2004
Sponsor: Sanofi-Aventis Australia Pty Ltd
Risk class distribution
Devices by risk class
Class Im
7
100.0% of total
About this profile
Explore comprehensive manufacturer profile for ROVIPHARM through Pure Global AI's free Australia TGA ARTG medical device database. This company has manufactured 7 medical devices registered with TGA ARTG across 1 device class. This manufacturer is based in France. Their registration history spans from Apr 29, 2004 to Jun 20, 2024.
This page provides detailed insights including recent device registrations, risk class distribution (Class Im: 7), and complete regulatory information from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices.
Free Manufacturer ProfilePowered by Pure Global AI7 Devices1 Device Classes